RAYDEL GROUP
Discover our latest research, achievements and stories from across the RAYDEL global network.
The RAYDEL HDL Research Institute has published a new study in Pharmaceuticals (2026) showing that combining Policosanol (Raydel®) with statins significantly outperforms individual treatments in lipid restoration and organ protection. This synergy boosts antioxidant defenses to shield the liver, brain, and reproductive health from chronic metabolic stress, offering a superior approach to managing cholesterol complications.
Read the full study
RAYDEL Australia has been selected as a Finalist in not just one, but two prestigious categories in the 2025 NSW Export Awards, presented by the Export Council of Australia. This is a tremendous recognition, and we want to thank you—our customers, partners, and supporters—for being part of this journey.
Read More
In an interview with a correspondent from the Vietnam News Agency’s Seoul Bureau, Mr. Lee explained that his story is not about making the perfect decision, but rather about how to approach making the best possible choice.
Read More
Stanford University’s “World’s Top 2% Scientists” list, based on Scopus data and published with Elsevier, recognizes the most influential researchers worldwide. Dr. Kyung Hyun Cho, Head of RAYDEL Research Institute, ranked 98,958th—placing him in the top 1% globally.
Read More
RAYDEL proudly sponsored and participated in the 2nd Symposium on the Longevity Factor HDL, held at the Grand Hyatt Seoul. This prestigious event brought together leading researchers to discuss the crucial role of HDL (high-density lipoprotein) in vascular health and longevity.
Read More
RAYDEL’s Managing Director, Byong Ku Lee received the prestigious Carlos Finlay Medal from the Cuban government. To learn more about his journey and the story behind RAYDEL, visit the CEO’s website.
Visit Website